New Class of Inhibitors of Amyloid-β Fibril Formation
Open Access
- 1 November 2002
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 277 (45), 42881-42890
- https://doi.org/10.1074/jbc.m206593200
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- The Challenge of Inhibiting Aβ PolymerizationCurrent Medicinal Chemistry, 2002
- γ-Secretase as a Target for Alzheimers DiseaseCurrent Topics in Medicinal Chemistry, 2002
- New developments in animal models of Alzheimer’s diseaseCurrent Neurology and Neuroscience Reports, 2001
- Potential Treatment Opportunities for Alzheimer's Disease Through Inhibition of Secretases and Aβ ImmunizationJournal of Molecular Neuroscience, 2001
- Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐ProteinAnnals of the New York Academy of Sciences, 2000
- Amyloid diseases: Abnormal protein aggregation in neurodegenerationProceedings of the National Academy of Sciences of the United States of America, 1999
- Mutations in the Transmembrane Domain of APP Altering γ-Secretase SpecificityBiochemistry, 1997
- Alzheimer's Disease--Genotypes, Phenotype, and TreatmentsScience, 1997
- The Profile of Soluble Amyloid β Protein in Cultured Cell MediaJournal of Biological Chemistry, 1996
- Aggregation State and Neurotoxic Properties of Alzheimer Beta-Amyloid PeptideNeurodegeneration, 1995